| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 31 Oct 2025 | 28 Oct 2025 |
| Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and Half Year ended 30th September 2025. Outcome of Board Meeting dated 31st October, 2025. Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & Half year ended 30th September, 2025. (As Per BSE Announcement Dated on:31.10.2025) | ||
| Board Meeting | 12 Aug 2025 | 7 Aug 2025 |
| Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter ended 30th June 2025. Outcome of Board Meeting dated 12th August, 2025 (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 12 May 2025 | 2 May 2025 |
| Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & year ended 31st March 2025 and recommend the Equity Dividend (If Any) for the Financial Year 2024-25. In the meeting of Board of Directors of the Company held on 12.05.2025 i.e. today, the Board has inter-alia considered and approved the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and year ended 31st March, 2025 together with the Auditors Report thereon. The Board has also recommended 10% Equity Dividend (One rupee per share) on Equity Capital of the Company for the Financial Year 2024-25. (As Per BSE Announcement Dated on 12.05.2025) | ||
| Board Meeting | 7 Feb 2025 | 29 Jan 2025 |
| SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & Nine months ended 31st December 2024. Submission of Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter & nine months ended 31st December, 2024. The Board of Directors at its meeting held on 07.02.2025 i.e. today has inter-alia considered and approved the Unaudited Financial Results (Standalone & Consolidated) together with the Limited Review Reports of the Auditors for the Quarter & Nine months ended 31st December, 2024 (As Per Bse Announcement Dated on 07.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.